Effect of Intraperitoneal Drain Placement on Postoperative Outcomes Following Laparoscopic Appendectomy in Adult Patients With Perforated Appendicitis
LADPA
1 other identifier
observational
500
1 country
1
Brief Summary
Acute appendicitis is the most common acute abdomen, and a small number of patients can progress to perforated appendicitis, which has significantly higher complications than non-perforated appendicitis. Appendectomy is the only option for treating perforated appendicitis. Optimizing the diagnosis and treatment of perforated appendicitis is of great significance to improve its clinical outcomes and save medical resources. There is a consensus that drainage should not be placed after surgery for non-perforated appendicitis, but the decision to place drainage for perforated appendicitis remains controversial. Several retrospective studies have shown no benefit in postoperative recovery and hospital stay, and may lead to increased infectious complications and longer hospital stays. A small number of prospective studies have shown similar conclusions, but the sample size is too small, most of them are children, and there is a lack of large-scale multicenter studies. The investigators' preliminary retrospective survey suggests that in China, most surgeons still commonly place drains for peace of mind after surgery with perforated appendicitis in adults without seeing a clear benefit, so there is a need for a multicenter prospective randomized controlled study to evaluate the need for drainage placement after perforated appendicitis and to guide clinical practice with evidence. To study the effect of abdominal drainage on the postoperative clinical outcomes of adult patients with perforated appendicitis, mainly including: infectious complications (residual infection or abscess in the abdominal cavity, incision infection, fecal fistula, etc.), case fatality rate, pain score, length of hospital stay (LOS), quality of life (QOL) score, etc.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2024
CompletedFirst Submitted
Initial submission to the registry
December 23, 2024
CompletedFirst Posted
Study publicly available on registry
April 15, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2025
CompletedApril 15, 2025
April 1, 2025
12 months
December 23, 2024
April 7, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Incision infection rate
Superficial tissue infections, such as those at the site of the surgical Trocar foramen (epidermal or subcutaneous), do not enter the abdominal cavity
From enrollment to 30 days postoperatively
Incidence of intra-abdominal abscess
Residual infection in the abdominal cavity forms an abscess.The incidence of intra-abdominal abscess after surgery will be compared between the two groups
From enrollment to 30 days postoperatively
Incidence of fecal leakage
Dehiscence of the stump of the appendix causes fecal residue to enter the abdominal cavity
From enrollment to 30 days postoperatively
Secondary Outcomes (3)
Length of hospital stay
From enrollment to 30 days postoperatively
Pain scores
From enrollment to 30 days postoperatively
Quality of life scores
From enrollment to 30 days postoperatively
Study Arms (1)
Place an abdominal drain
Place an abdominal drain
Interventions
Eligibility Criteria
Patients with acute perforated appendicitis \>18 years of age
You may qualify if:
- Age: ≥ 18 years old (no upper limit);
- Perforated appendicitis or suspected perforated appendicitis who intends to undergo laparoscopic appendectomy;
- Patients and their families (or legal representatives) are able to understand the study protocol and voluntarily participate in this study, and sign informed consent.
You may not qualify if:
- Whole abdominal pus was found during the operation;
- Open or laparoscopic conversion to open appendectomy;
- Appendiceal tumors (including postoperative pathology)
- Pregnancy or perinatal period;
- AIDS, tuberculosis, liver cirrhosis, uremia, aplastic anemia, essential thrombocytopenia, inflammatory bowel disease, organ transplantation;
- Long-term or preoperative use of immunosuppressants/glucocorticoids/tumor chemotherapy drugs/targeted drugs/immunodrugs;
- Malignant tumors (including leukemia and lymphoma) disease status, recurrence/metastasis, and perioperative period;
- Drunk, drug abuse/drug addicts;
- Organ dysfunction/failure;
- Those who are transferred to the ICU for various reasons;
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Affiliated Hospital of Qingdao University
Qingdao, Shandong, 266000, China
Biospecimen
Excision of the appendix Intraperitoneal pus
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Target Duration
- 30 Days
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 23, 2024
First Posted
April 15, 2025
Study Start
June 1, 2024
Primary Completion
May 31, 2025
Study Completion
May 31, 2025
Last Updated
April 15, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share
secrecy